These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 18673419
1. Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits. Alarma-Estrany P, Crooke A, Mediero A, Peláez T, Pintor J. J Pineal Res; 2008 Nov; 45(4):468-75. PubMed ID: 18673419 [Abstract] [Full Text] [Related]
2. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits. Alarma-Estrany P, Guzman-Aranguez A, Huete F, Peral A, Plourde R, Pelaez T, Yerxa B, Pintor J. J Pharmacol Exp Ther; 2011 Jun; 337(3):703-9. PubMed ID: 21368006 [Abstract] [Full Text] [Related]
3. Effects of timolol, terbutaline and forskolin on IOP, aqueous humour formation and ciliary cyclic AMP levels in the bovine eye. Shahidullah M, Wilson WS, Millar C. Curr Eye Res; 1995 Jul; 14(7):519-28. PubMed ID: 7587297 [Abstract] [Full Text] [Related]
4. Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells. Dortch-Carnes J, Tosini G. Exp Eye Res; 2013 Feb; 107():1-10. PubMed ID: 23201027 [Abstract] [Full Text] [Related]
5. Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. Alarma-Estrany P, Crooke A, Peral A, Pintor J. Auton Neurosci; 2007 Dec 30; 137(1-2):63-6. PubMed ID: 17804303 [Abstract] [Full Text] [Related]
6. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Russell KR, Wang DR, Potter DE. Exp Eye Res; 2000 May 30; 70(5):675-82. PubMed ID: 10870526 [Abstract] [Full Text] [Related]
7. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma. Crooke A, Huete-Toral F, Martínez-Águila A, Martín-Gil A, Pintor J. J Pharmacol Exp Ther; 2013 Jul 30; 346(1):138-45. PubMed ID: 23591996 [Abstract] [Full Text] [Related]
8. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. Ogidigben M, Chu TC, Potter DE. J Pharmacol Exp Ther; 1993 Nov 30; 267(2):822-7. PubMed ID: 7902435 [Abstract] [Full Text] [Related]
9. Adenine nucleotide effect on intraocular pressure: Involvement of the parasympathetic nervous system. Peral A, Gallar J, Pintor J. Exp Eye Res; 2009 Jun 15; 89(1):63-70. PubMed ID: 19250934 [Abstract] [Full Text] [Related]
10. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT. Andrés-Guerrero V, Alarma-Estrany P, Molina-Martínez IT, Peral A, Herrero-Vanrell R, Pintor J. Exp Eye Res; 2009 Mar 15; 88(3):504-11. PubMed ID: 19056382 [Abstract] [Full Text] [Related]
11. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Ogidigben MJ, Chu TC, Potter DE. Exp Eye Res; 2001 Mar 15; 72(3):331-9. PubMed ID: 11180982 [Abstract] [Full Text] [Related]
12. Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor. Crooke A, Guzman-Aranguez A, Mediero A, Alarma-Estrany P, Carracedo G, Pelaez T, Peral A, Pintor J. Curr Eye Res; 2015 Jan 15; 40(1):56-65. PubMed ID: 24892818 [Abstract] [Full Text] [Related]
13. Effect of Melatonin and Its Analogs on Tear Secretion. Navarro Gil FJ, Huete-Toral F, Crooke A, Dominguez Godinez CO, Carracedo G, Pintor J. J Pharmacol Exp Ther; 2019 Oct 15; 371(1):186-190. PubMed ID: 31371479 [Abstract] [Full Text] [Related]
14. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines. Tsotinis A, Vlachou M, Papahatjis DP, Calogeropoulou T, Nikas SP, Garratt PJ, Piccio V, Vonhoff S, Davidson K, Teh MT, Sugden D. J Med Chem; 2006 Jun 15; 49(12):3509-19. PubMed ID: 16759094 [Abstract] [Full Text] [Related]
15. Ocular hypotensive activity of pirbuterol eye drops in rabbits. Bonomi L, Perfetti S, Bellucci R, De Franco I. J Ocul Pharmacol; 1991 Jun 15; 7(3):191-4. PubMed ID: 1686050 [Abstract] [Full Text] [Related]
16. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate). Pang IH, Moll H, McLaughlin MA, Knepper PA, De Santis L, Epstein DL, Clark AF. Exp Eye Res; 2001 Dec 15; 73(6):815-25. PubMed ID: 11846512 [Abstract] [Full Text] [Related]
17. Effects of selective beta 1- and beta 2-adrenoreceptor agonists and antagonists on intraocular pressure in the cat. Colasanti BK, Trotter RR. Invest Ophthalmol Vis Sci; 1981 Jan 15; 20(1):69-76. PubMed ID: 6108938 [Abstract] [Full Text] [Related]
18. Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice. Han J, Xu Y, Yu CX, Shen J, Wei YM. Eur J Pharmacol; 2008 Oct 10; 594(1-3):125-31. PubMed ID: 18706407 [Abstract] [Full Text] [Related]
19. Hypotensive effect of UDP on intraocular pressure in rabbits. Markovskaya A, Crooke A, Guzmán-Aranguez AI, Peral A, Ziganshin AU, Pintor J. Eur J Pharmacol; 2008 Jan 28; 579(1-3):93-7. PubMed ID: 18031728 [Abstract] [Full Text] [Related]
20. Potential sites of action of TNPA: a dopamine-2 receptor agonist. Chu E, Chu TC, Potter DE. Exp Eye Res; 1999 Dec 28; 69(6):611-6. PubMed ID: 10620390 [Abstract] [Full Text] [Related] Page: [Next] [New Search]